The Readout LOUD

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. Subscribe today on iTunes, Spotify, SoundCloud, and Stitcher.

Play
The Readout LOUD

Listen: Pharma’s future in China, CRISPR meets Netflix, & where VC dollars come from

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Relitigating Vioxx, industry growing pains, & how biotech VC works

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Congressional paralysis, drug shortages, & biotech’s foul mood

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Vaping upheaval, DNA test dynamics, & the future of genome editing

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Unicorn growth spurts, Amgen’s future, & mice on Twitter

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Pelosi’s drug pricing plan, Moderna’s mRNA drug factories, and a DIY disease cure

By Adam Feuerstein and Rebecca Robbins

Anastasia Synn
The Readout LOUD

A cyborg magician explains why she implanted 26 microchips and magnets in her body

By Rebecca Robbins

Play
The Readout LOUD

Listen: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Purdue, J&J, and a week of big opioid crisis news

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Sarepta keeps a secret, an online army mobilizes, & China embraces biotech

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: The serious side of spit kits, how BiTEs leave a mark, & Sarepta’s sluggish study

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Novartis and the no good, very bad week

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Canadian pills, corporate jets, & racists with spit kits

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Vertex’s regime change, the return of Ebola, & the rise of digital health

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Elon Musk’s monkey cyborg, Gilead’s shifting future, & an app for anxiety

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: A whirlwind week in Washington, Sean Parker’s mansion, & remembering a resonant voice in biotech

By Damian Garde and Rebecca Robbins

Play
The Readout LOUD

Listen: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

By Damian Garde and Adam Feuerstein

Play
The Readout LOUD

Listen: A controversial desire drug, courtroom genealogy, & the quest for longer life

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Biohacking meets bureaucracy, and the latest twist in CRISPR world

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: A special episode from the halls of the ASCO meeting

By Adam Feuerstein and Matthew Herper

Play
The Readout LOUD

Listen: Feuding professors, failing businesses, and journalism 101

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Your ASCO preview, genetic whiplash, and a journalist’s experience with cancer

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Drug pricing partisanship, tech’s march into health care, and Tinder for clinical trials

By Damian Garde and Rebecca Robbins

Play
The Readout LOUD

Listen: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

By Damian Garde and Adam Feuerstein

Play
The Readout LOUD

Listen: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

By Damian Garde and Adam Feuerstein

Play
The Readout LOUD

Listen: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Democratizing CRISPR, drugging the undruggable, and reading pharma’s fine print

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Play
The Readout LOUD

Listen: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy